CLINICAL_TRIALS trial_result · 2023-05-25

Clinical Trial Update: Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome [Phase 2]

Phase 2 trial update on a novel cognitive treatment targeting Epidiolex for Sturge-Weber Syndrome has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Anne Comi, MD | Conditions: Sturge-Weber Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2023-05-25